Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series.

Vallon-Christersson J, Häkkinen J, Hegardt C, Saal LH, Larsson C, Ehinger A, Lindman H, Olofsson H, Sjöblom T, Wärnberg F, Ryden L, Loman N, Malmberg M, Borg Å, Staaf J.

Sci Rep. 2019 Aug 21;9(1):12184. doi: 10.1038/s41598-019-48570-x.

2.

ASO Author Reflections: SPIO, a New Sentinel Node Tracer with Interesting Future Clinical Applications.

Wärnberg F, Karakatsanis A.

Ann Surg Oncol. 2019 Dec;26(Suppl 3):639-640. doi: 10.1245/s10434-019-07520-7. Epub 2019 Jun 17. No abstract available.

3.

Effect of preoperative injection of superparamagnetic iron oxide particles on rates of sentinel lymph node dissection in women undergoing surgery for ductal carcinoma in situ (SentiNot study).

Karakatsanis A, Hersi AF, Pistiolis L, Olofsson Bagge R, Lykoudis PM, Eriksson S, Wärnberg F; SentiNot Trialists Group.

Br J Surg. 2019 May;106(6):720-728. doi: 10.1002/bjs.11110. Epub 2019 Mar 6.

PMID:
30839104
4.

Long-Term Outcome After Retro-Areolar Versus Peri-Tumoral Injection of Superparamagnetic Iron Oxide Nanoparticles (SPIO) for Sentinel Lymph Node Detection in Breast Cancer Surgery.

Wärnberg F, Stigberg E, Obondo C, Olofsson H, Abdsaleh S, Wärnberg M, Karakatsanis A.

Ann Surg Oncol. 2019 May;26(5):1247-1253. doi: 10.1245/s10434-019-07239-5. Epub 2019 Mar 4.

5.

Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.

Strell C, Paulsson J, Jin SB, Tobin NP, Mezheyeuski A, Roswall P, Mutgan C, Mitsios N, Johansson H, Wickberg SM, Svedlund J, Nilsson M, Hall P, Mulder J, Radisky DC, Pietras K, Bergh J, Lendahl U, Wärnberg F, Östman A.

J Natl Cancer Inst. 2019 Sep 1;111(9):983-995. doi: 10.1093/jnci/djy234.

PMID:
30816935
6.

A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.

Hersi AF, Eriksson S, Ramos J, Abdsaleh S, Wärnberg F, Karakatsanis A.

Eur J Surg Oncol. 2019 Apr;45(4):544-549. doi: 10.1016/j.ejso.2018.10.064. Epub 2018 Oct 23.

PMID:
30401506
7.

A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk.

Bremer T, Whitworth PW, Patel R, Savala J, Barry T, Lyle S, Leesman G, Linke SP, Jirström K, Zhou W, Amini RM, Wärnberg F.

Clin Cancer Res. 2018 Dec 1;24(23):5895-5901. doi: 10.1158/1078-0432.CCR-18-0842. Epub 2018 Jul 27.

8.

Survival and risk of breast cancer recurrence after breast reconstruction with deep inferior epigastric perforator flap.

Svee A, Mani M, Sandquist K, Audolfsson T, Folkvaljon Y, Isern AE, Ringberg A, Manjer J, Falk-Delgado A, Wärnberg F.

Br J Surg. 2018 Oct;105(11):1446-1453. doi: 10.1002/bjs.10888. Epub 2018 Jul 12.

PMID:
29999520
9.

Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.

Sjöström M, Staaf J, Edén P, Wärnberg F, Bergh J, Malmström P, Fernö M, Niméus E, Fredriksson I.

Breast Cancer Res. 2018 Jul 4;20(1):64. doi: 10.1186/s13058-018-0978-y.

10.

Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ.

Wadsten C, Wennstig AK, Garmo H, Nilsson G, Blomqvist C, Holmberg L, Fredriksson I, Wärnberg F, Sund M.

Breast Cancer Res Treat. 2018 Aug;171(1):95-101. doi: 10.1007/s10549-018-4803-1. Epub 2018 May 5.

PMID:
29730730
11.

Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population-based cohort study.

Eriksson L, Bergh J, Humphreys K, Wärnberg F, Törnberg S, Czene K.

Int J Cancer. 2018 Sep 1;143(5):1093-1104. doi: 10.1002/ijc.31411. Epub 2018 Apr 17.

12.

Meta-analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancer.

Karakatsanis A, Tasoulis MK, Wärnberg F, Nilsson G, MacNeill F.

Br J Surg. 2018 Apr;105(5):469-481. doi: 10.1002/bjs.10807. Review.

PMID:
29603132
13.

Optimisation of breast MRI compatibility after sentinel node biopsy with paramagnetic tracers.

Karakatsanis A, Obondo C, Abdsaleh S, Hersi AF, Eriksson S, Wärnberg F.

Eur J Surg Oncol. 2018 May;44(5):731-732. doi: 10.1016/j.ejso.2018.01.241. Epub 2018 Feb 6. No abstract available.

PMID:
29478740
14.

High experienced continuity in breast cancer care is associated with high health related quality of life.

Plate S, Emilsson L, Söderberg M, Brandberg Y, Wärnberg F.

BMC Health Serv Res. 2018 Feb 20;18(1):127. doi: 10.1186/s12913-018-2925-0.

15.

Simplifying Logistics and Avoiding the Unnecessary in Patients With Breast Cancer Undergoing Sentinel Node Biopsy. A Prospective Feasibility Trial of the Preoperative Injection of Super Paramagnetic Iron Oxide Nanoparticles.

Karakatsanis A, Olofsson H, Stålberg P, Bergkvist L, Abdsaleh S, Wärnberg F.

Scand J Surg. 2018 Jun;107(2):130-137. doi: 10.1177/1457496917738867. Epub 2017 Nov 13.

PMID:
29132268
16.

Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer.

Karakatsanis A, Daskalakis K, Stålberg P, Olofsson H, Andersson Y, Eriksson S, Bergkvist L, Wärnberg F.

Br J Surg. 2017 Nov;104(12):1675-1685. doi: 10.1002/bjs.10606. Epub 2017 Sep 6.

PMID:
28877348
17.

Risk of death from breast cancer after treatment for ductal carcinoma in situ.

Wadsten C, Garmo H, Fredriksson I, Sund M, Wärnberg F.

Br J Surg. 2017 Oct;104(11):1506-1513. doi: 10.1002/bjs.10589. Epub 2017 Aug 22.

PMID:
28832961
18.

Ductal Breast Carcinoma In Situ: Mammographic Features and Its Relation to Prognosis and Tumour Biology in a Population Based Cohort.

Zhou W, Sollie T, Tot T, Blomqvist C, Abdsaleh S, Liljegren G, Wärnberg F.

Int J Breast Cancer. 2017;2017:4351319. doi: 10.1155/2017/4351319. Epub 2017 Feb 14.

19.

A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years.

Wadsten C, Heyman H, Holmqvist M, Ahlgren J, Lambe M, Sund M, Wärnberg F.

Acta Oncol. 2016 Nov;55(11):1338-1343. Epub 2016 Aug 22.

PMID:
27548561
20.

Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.

Lesurf R, Aure MR, Mørk HH, Vitelli V; Oslo Breast Cancer Research Consortium (OSBREAC), Lundgren S, Børresen-Dale AL, Kristensen V, Wärnberg F, Hallett M, Sørlie T.

Cell Rep. 2016 Jul 26;16(4):1166-1179. doi: 10.1016/j.celrep.2016.06.051. Epub 2016 Jul 7.

21.

The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.

Karakatsanis A, Christiansen PM, Fischer L, Hedin C, Pistioli L, Sund M, Rasmussen NR, Jørnsgård H, Tegnelius D, Eriksson S, Daskalakis K, Wärnberg F, Markopoulos CJ, Bergkvist L.

Breast Cancer Res Treat. 2016 Jun;157(2):281-294. doi: 10.1007/s10549-016-3809-9. Epub 2016 Apr 27.

22.

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.

Borgquist S, Zhou W, Jirström K, Amini RM, Sollie T, Sørlie T, Blomqvist C, Butt S, Wärnberg F.

BMC Cancer. 2015 Jun 11;15:468. doi: 10.1186/s12885-015-1479-3.

23.

Breast cancer with neoductgenesis: histopathological criteria and its correlation with mammographic and tumour features.

Zhou W, Sollie T, Tot T, Pinder SE, Amini RM, Blomqvist C, Fjällskog ML, Christensson G, Abdsaleh S, Wärnberg F.

Int J Breast Cancer. 2014;2014:581706. doi: 10.1155/2014/581706. Epub 2014 Oct 8.

24.

Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial.

Wärnberg F, Garmo H, Emdin S, Hedberg V, Adwall L, Sandelin K, Ringberg A, Karlsson P, Arnesson LG, Anderson H, Jirström K, Holmberg L.

J Clin Oncol. 2014 Nov 10;32(32):3613-8. doi: 10.1200/JCO.2014.56.2595. Epub 2014 Oct 13.

PMID:
25311220
25.

Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.

Fleischer T, Frigessi A, Johnson KC, Edvardsen H, Touleimat N, Klajic J, Riis ML, Haakensen VD, Wärnberg F, Naume B, Helland A, Børresen-Dale AL, Tost J, Christensen BC, Kristensen VN.

Genome Biol. 2014;15(8):435. doi: 10.1186/PREACCEPT-2333349012841587. Epub 2014 Aug 22.

26.

The target for statins, HMG-CoA reductase, is expressed in ductal carcinoma-in situ and may predict patient response to radiotherapy.

Butt S, Butt T, Jirström K, Hartman L, Amini RM, Zhou W, Wärnberg F, Borgquist S.

Ann Surg Oncol. 2014 Sep;21(9):2911-9. doi: 10.1245/s10434-014-3708-4. Epub 2014 Apr 29.

PMID:
24777857
27.

A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.

Zhou W, Johansson C, Jirström K, Ringberg A, Blomqvist C, Amini RM, Fjallskog ML, Wärnberg F.

Int J Breast Cancer. 2013;2013:582134. doi: 10.1155/2013/582134. Epub 2013 Dec 29.

28.

Genomic copy number imbalances associated with bone and non-bone metastasis of early-stage breast cancer.

Liu Y, Zhou R, Baumbusch LO, Tsavachidis S, Brewster AM, Do KA, Sahin A, Hortobagyi GN, Taube JH, Mani SA, Aarøe J, Wärnberg F, Børresen-Dale AL, Mills GB, Thompson PA, Bondy ML.

Breast Cancer Res Treat. 2014 Jan;143(1):189-201. doi: 10.1007/s10549-013-2796-3. Epub 2013 Dec 4.

29.

Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events.

Karlsson E, Sandelin K, Appelgren J, Zhou W, Jirström K, Bergh J, Wärnberg F.

Eur J Cancer. 2014 Feb;50(3):517-24. doi: 10.1016/j.ejca.2013.10.020. Epub 2013 Nov 22.

PMID:
24275214
30.

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study.

Zhou W, Jirström K, Amini RM, Fjällskog ML, Sollie T, Lindman H, Sørlie T, Blomqvist C, Wärnberg F.

BMC Cancer. 2013 Oct 30;13:512. doi: 10.1186/1471-2407-13-512.

31.

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors.

Klajic J, Fleischer T, Dejeux E, Edvardsen H, Warnberg F, Bukholm I, Lønning PE, Solvang H, Børresen-Dale AL, Tost J, Kristensen VN.

BMC Cancer. 2013 Oct 5;13:456. doi: 10.1186/1471-2407-13-456.

32.

Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?

Crona J, Granberg D, Norlén O, Wärnberg F, Stålberg P, Hellman P, Björklund P.

World J Surg. 2013 Jul;37(7):1701-6. doi: 10.1007/s00268-013-2037-2.

PMID:
23592057
33.

Gene rearrangements in hormone receptor negative breast cancers revealed by mate pair sequencing.

Jiao X, Hooper SD, Djureinovic T, Larsson C, Wärnberg F, Tellgren-Roth C, Botling J, Sjöblom T.

BMC Genomics. 2013 Mar 12;14:165. doi: 10.1186/1471-2164-14-165.

34.

[Antibiotic prophylaxis in breast surgery? Yes, but not for everyone. Quality data from the Uppsala county council provides draft for guidelines].

Adwall L, Liljegren G, Olsson L, Wärnberg F.

Lakartidningen. 2013 Jan 30-Feb 5;110(5):213-5. Swedish. No abstract available.

PMID:
23451672
35.

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007: a population-based study.

Walters S, Maringe C, Butler J, Rachet B, Barrett-Lee P, Bergh J, Boyages J, Christiansen P, Lee M, Wärnberg F, Allemani C, Engholm G, Fornander T, Gjerstorff ML, Johannesen TB, Lawrence G, McGahan CE, Middleton R, Steward J, Tracey E, Turner D, Richards MA, Coleman MP; ICBP Module 1 Working Group.

Br J Cancer. 2013 Mar 19;108(5):1195-208. doi: 10.1038/bjc.2013.6. Epub 2013 Feb 28.

36.

Placental weight and mortality in premenopausal breast cancer by tumor characteristics.

Hajiebrahimi MH, Bahmanyar S, Lambe M, Adolfsson J, Fornander T, Wärnberg F, Cnattingius S.

Breast Cancer Res Treat. 2013 Jan;137(1):297-305. doi: 10.1007/s10549-012-2337-5. Epub 2012 Nov 13.

PMID:
23149466
37.

Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study.

Vichapat V, Garmo H, Holmqvist M, Liljegren G, Wärnberg F, Lambe M, Fornander T, Adolfsson J, Lüchtenborg M, Holmberg L.

J Clin Oncol. 2012 Oct 1;30(28):3478-85. Epub 2012 Aug 27.

PMID:
22927521
38.

Impact of comorbidity on management and mortality in women diagnosed with breast cancer.

Berglund A, Wigertz A, Adolfsson J, Ahlgren J, Fornander T, Wärnberg F, Lambe M.

Breast Cancer Res Treat. 2012 Aug;135(1):281-9. doi: 10.1007/s10549-012-2176-4. Epub 2012 Jul 26.

PMID:
22829398
39.

Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling.

Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland Å, Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale AL.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2802-7. doi: 10.1073/pnas.1108781108. Epub 2011 Sep 9.

40.

Breast cancer associated with primary hyperparathyroidism: a nested case control study.

Norenstedt S, Granath F, Ekbom A, Bergh J, Lambe M, Adolfsson J, Warnberg F, Zedenius J, Nilsson IL.

Clin Epidemiol. 2011 Mar 25;3:103-6. doi: 10.2147/CLEP.S17298.

41.

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.

Zhou W, Jirström K, Johansson C, Amini RM, Blomqvist C, Agbaje O, Wärnberg F.

BMC Cancer. 2010 Nov 30;10:653. doi: 10.1186/1471-2407-10-653.

42.

Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer.

Muggerud AA, Hallett M, Johnsen H, Kleivi K, Zhou W, Tahmasebpoor S, Amini RM, Botling J, Børresen-Dale AL, Sørlie T, Wärnberg F.

Mol Oncol. 2010 Aug;4(4):357-68. doi: 10.1016/j.molonc.2010.06.007. Epub 2010 Jun 26.

43.

Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancer.

Koliadi A, Nilsson C, Holmqvist M, Holmberg L, de La Torre M, Wärnberg F, Fjällskog ML.

Acta Oncol. 2010 Aug;49(6):816-20. doi: 10.3109/02841861003691937.

PMID:
20307242
44.

Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer.

Muggerud AA, Rønneberg JA, Wärnberg F, Botling J, Busato F, Jovanovic J, Solvang H, Bukholm I, Børresen-Dale AL, Kristensen VN, Sørlie T, Tost J.

Breast Cancer Res. 2010;12(1):R3. doi: 10.1186/bcr2466. Epub 2010 Jan 7.

45.

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.

Niméus-Malmström E, Koliadi A, Ahlin C, Holmqvist M, Holmberg L, Amini RM, Jirström K, Wärnberg F, Blomqvist C, Fernö M, Fjällskog ML.

Int J Cancer. 2010 Aug 15;127(4):961-7. doi: 10.1002/ijc.25091.

46.

Mammographic casting-type calcifications is not a prognostic factor in unifocal small invasive breast cancer: a population-based retrospective cohort study.

Månsson E, Bergkvist L, Christenson G, Persson C, Wärnberg F.

J Surg Oncol. 2009 Dec 15;100(8):670-4. doi: 10.1002/jso.21405.

PMID:
19771563
47.

Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution.

Zhou W, Muggerud AA, Vu P, Due EU, Sørlie T, Børresen-Dale AL, Wärnberg F, Langerød A.

Mol Oncol. 2009 Jun;3(3):214-9. doi: 10.1016/j.molonc.2009.03.001. Epub 2009 Apr 2.

48.

Quality aspects of the tissue microarray technique in a population-based cohort with ductal carcinoma in situ of the breast.

Wärnberg F, Amini RM, Goldman M, Jirström K.

Histopathology. 2008 Dec;53(6):642-9. doi: 10.1111/j.1365-2559.2008.03156.x.

PMID:
19076680
49.

Comparison of core needle biopsy and surgical specimens in malignant breast lesions regarding histological features and hormone receptor expression.

Abdsaleh S, Wärnberg F, Azavedo E, Lindgren PG, Amini RM.

Histopathology. 2008 May;52(6):773-5. doi: 10.1111/j.1365-2559.2008.03014.x. Epub 2008 Apr 2. No abstract available.

PMID:
18393972
50.

Paget's disease of the nipple in a population based cohort.

Dalberg K, Hellborg H, Wärnberg F.

Breast Cancer Res Treat. 2008 Sep;111(2):313-9. Epub 2007 Oct 19.

PMID:
17952590

Supplemental Content

Loading ...
Support Center